U.S. federal trademark · Serial No. 78300887 · Reg. No. 3402869
Pharmaceutical and biological product development consultation relating to monoclonal antibodies; and pharmaceutical and biological product development for others relating to monoclonal antibodies
Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for therapeutic use for the treatment of cancer and proliferative cell diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.